1. Critical reappraisal of short-acting bronchodilators for pediatric respiratory diseases.
- Author
-
Licari, Amelia, Manti, Sara, Mastellone, Francesco, Miraglia Del Giudice, Michele, Marseglia, Gian Luigi, Tosca, Maria Angela, Andrenacci, Beatrice, Capristo, Carlo, Cutrera, Renato, Di Cicco, Maria Elisa, Fierro, Vincenzo, Leone, Maddalena, Naso, Matteo, Pezone, Ilaria, and Trincianti, Chiara
- Subjects
PARASYMPATHOMIMETIC agents ,HEALTH literacy ,RESPIRATORY organ sounds ,PATIENT safety ,BRONCHIOLE diseases ,RESPIRATORY diseases ,TREATMENT duration ,TREATMENT effectiveness ,PEDIATRICS ,BRONCHODILATOR agents ,ASTHMA ,CHILDREN - Abstract
Short-acting bronchodilators are a class of medications commonly used to treat asthma, chronic obstructive pulmonary disease, and other respiratory conditions. The use of these medications has evolved over time as we have gained a better understanding of their effectiveness and safety in the pediatric population. This comprehensive review synthesizes the current understanding of short-acting β2-agonists and short-acting anticholinergics in children. It addresses indications, contraindications, safety considerations, and highlights areas where further research is needed to guide the most effective use of short-acting bronchodilators. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF